Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Dermatology | Family Medicine | Oncology | Pathology | Conference News

Back to Journal Articles

AAD: Hyaluronic Acid Increases Fibroblast Activity

Last Updated: March 05, 2010.

 

And, nanotechnology shows promise for use in treatments for melanoma, other skin conditions

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Recent research suggests how the popular skin filler hyaluronic acid works to rejuvenate photoaged skin, and nanotechnology may have potential for use in cosmetic products and topical medical treatments, according to two presentations this week at the annual meeting of the American Academy of Dermatology, held from March 5 to 9 in Miami Beach, Fla.

FRIDAY, March 5 (HealthDay News) -- Recent research suggests how the popular skin filler hyaluronic acid works to rejuvenate photoaged skin, and nanotechnology may have potential for use in cosmetic products and topical medical treatments, according to two presentations this week at the annual meeting of the American Academy of Dermatology, held from March 5 to 9 in Miami Beach, Fla.

In one presentation, Dana L. Sachs, M.D., of the University of Michigan in Ann Arbor, presented results of an initial study of six patients showing that hyaluronic acid injections stimulate production of type I collagen, and a subsequent study of 11 patients showing that the mechanism behind this process is increased activity of fibroblasts, which were observed at four and 13 weeks following injection to be in a 'stretched' configuration that correlates with increased collagen production.

In a second presentation, Adnan Nasir, M.D., of the University of North Carolina in Chapel Hill, discussed the pros and cons of nanotechnology and how nanoparticles may someday be used to enhance the effectiveness of cosmetic products such as sunscreens, shampoos and conditioners; anti-aging products such as retinoids, antioxidants, botulinum toxin, and growth factors; and treatments for conditions such as melanoma, atopic dermatitis, and ichthyosis. However, he cautioned that the future of nanotechnology in dermatology depends on the results of an ongoing safety review by the U.S. Food and Drug Administration.

"Research in the area of nanotechnology has increased significantly over the years, and I think there will be considerable growth in this area in the near future," Nasir said in a statement. "The challenge is that a standard has not been set yet to evaluate the safety and efficacy of topical products that contain nanosized particles."

Press Release - Sachs
Press Release - Nasir
More Information

Copyright © 2010 HealthDay. All rights reserved.


Previous: Insulin Defects Linked to Impaired Female Reproduction Next: In Very Oldest, Dementia Rate Rises Exponentially

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.